AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JUN 12 - (NewsRx.com & NewsRx.net) -- Elderly women with osteoporosis can significantly and safely improve their bone mass with a combination therapy of hormone replacement and the bisphosphonate alendronate (Fosamax).
"Our study found that a combination therapy of hormone replacement and alendronate was well tolerated by elderly women with low bone mass. After 3 years of treatment, these women showed significantly greater increases in bone mass than we saw in similar women taking only one of the therapies," said lead author Susan Greenspan, MD, professor of medicine at the University of Pittsburgh School of Medicine and director of the Osteoporosis Prevention and Treatment Center at the University of Pittsburgh Medical Center. "Combination therapy is a safe, viable option for postmenopausal women who have been unable to improve their bone density with an individual therapy, or in women with osteoporosis severe enough to require a greater increase in bone density."
Earlier research has suggested similar results with younger women, but up to now little data were available on the effectiveness and safety of combination therapy in older, post-menopausal women.
The study was conducted with 373 women aged 65 to 90 years. At baseline, participants as a group had bone mass thin enough to be classified as osteopenia, a precursor of osteoporosis. Thirty-four percent of the women had osteoporosis.
Participants were evenly randomized to receive hormone replacement therapy (HRT) (conjugated estrogen with or without medroxyprogesterone) plus ...
Source: HighBeam Research, HRT is safe, effective for prevention, treatment in older women.